FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
FARGO is a randomised, phase IIa, multi-centre, placebo-controlled trial to compare Faecal Microbiota Transplant (FMT) with placebo in patients with primary sclerosing cholangitis (PSC) and concomitant inflammatory bowel disease.
Epistemonikos ID: 8fd4469bb7a473fb8eae58f48c51b887b61db83b
First added on: May 15, 2024